Journal Abbreviation: CANCER LETT Journal ISSN: 0304-3835 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)9.127440118 20229.7-43634 20219.756-45756 20208.67939342174 20197.36042634162 20186.50852830146 20176.49147229311 20166.37548926657
Journal ISSN: 1837-9664 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)3.3-- 20223.9-14669 20214.478-14324 20204.20772511142 20193.5657326460 20183.1825363923 20173.2494552710 20162.9162701660 20153.6091621091 20143.27189781 20132.63980470
Journal Impact Factor: 3.4 5-year Journal Impact Factor: 3.8 Source Normalized Impact per Paper (SNIP): 0.944 SCImago Journal Rank (SJR): 1.087 Speed 2023 Submission to first editorial decision (median days): 12 Submission to acceptance (median days): 150 ...
The journal publishes peer reviewed papers related to improving the understanding, prevention, and management of multiple areas related to cancer survivorship that can affect quality care, symptom management, function, and well-being. Editor Michael Feuerstein Journal Impact Factor 3.1 (2023) 5-year ...
1.6 (2023) 5-year Journal Impact Factor 1.4 (2023) Submission to first decision (median) 5 days Downloads 202,065 (2023) Calls for papers Collection Innovations in Early Detection and Treatment of Pancreatic Cancer Pancreatic cancer is a leading cause of cancer-related mortality. ...
Journal Impact Factor: 3.8 5-year Journal Impact Factor: 4.2 Source Normalized Impact per Paper (SNIP): 0.957 SCImago Journal Rank (SJR): 0.968 Speed 2023 Submission to first editorial decision (median days): 7 Submission to acceptance (median days): 138 ...
Oncology International Journal is dedicated to publish the contributions on all aspects of experimental and clinical cancer research. CTOIJ is a multidisciplinary, Open Access, peer reviewed journal accepts Research, Review Articles, Short Communications
Cancer Drug Resistance is a peer-reviewed journal led by Editor-in-Chief Godefridus J. (Frits) Peters, covering drug resistance research on breast cancer, lymphatic cancer, hematological malignancies, thyroid cancer, lung cancer, stomach cancer, esophage
Cancer Drug Resistance is a peer-reviewed journal led by Editor-in-Chief Godefridus J. (Frits) Peters, covering drug resistance research on breast cancer, lymphatic cancer, hematological malignancies, thyroid cancer, lung cancer, stomach cancer, esophage
YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)72.5359496 202278.5-63667 202169.800-66699 202060.7165262391 201953.0304352053 201851.8485250529 201742.7844950407 201637.1475646017 201534.2445541846 201437.4006139868 201337.9126636052 201235.0006932628 ...